Showing 15,061 - 15,080 results of 102,016 for search '(( 50 ((teer decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.04s Refine Results
  1. 15061
  2. 15062

    Simultaneously inhibition <i>Nlu-miR-34</i> and <i>NlInR2</i> in SW strain induced the decrease of SW BPHs. by Xinhai Ye (6857771)

    Published 2019
    “…<p>(A) Antagomir-34 (with two different quantities) and ds<i>NlInR2</i> (0.84 ng) were injected into the third instar SW strain nymphs, showed that injection of antagomir-34 decreased the ratio of SW type BPH (Chi-square test, 40ng: χ<sup>2</sup> = 5.8, df = 1, <i>p</i> = 0.003; 60ng: χ<sup>2</sup> = 7.9, df = 1, <i>p</i> = 0.042). …”
  3. 15063
  4. 15064
  5. 15065

    Change in average relative abundance of significantly different ASVs within distinct phyla classifications at all three time points for the three different treatments. by Charlotte H. Wang (8805353)

    Published 2020
    “…<p><b>A.</b> For the control treatment, the change in average relative abundance of significantly different bacteria taxa in their relative phyla classifications generally decreased throughout consecutive time points. …”
  6. 15066

    Copper-Based Complexes with Adamantane Ring-Conjugated <i>bis</i>(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma by Maria Beatrice Morelli (6281642)

    Published 2024
    “…The new ligand L<sup>2Ad</sup>, obtained by conjugating the bifunctional species bis­(3,5-dimethylpyrazol-1-yl)-acetate and the drug amantadine, was used as a chelator for the synthesis of new Cu complexes <b>1</b>–<b>5</b>. …”
  7. 15067

    Table_5_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx by Monica Franzese (8983097)

    Published 2022
    “…The cohorts were monitored from the 12th day after the first vaccine dose up to 1 month after the third vaccine dose for a total of eight time points and about 1 year of surveillance (T1 = 12 days after the first dose; T2 = 10 days after the second dose; T3 = 1 month after the second dose; T4 = 3 months after the second dose; T5 = 4 months after the second dose; T6 = 5 months after the second dose; T7 = 7 months after the second dose; T8 = 1 month after the third dose for Group 1; T8* = 9 months after the second dose for Group 2; T9 = 1 month after the third dose for Group 2). …”
  8. 15068
  9. 15069
  10. 15070
  11. 15071
  12. 15072
  13. 15073

    Adduct Formation between Alkali Metal Ions and Anionic LV<sup>V</sup>O<sub>2</sub><sup>-</sup> (L<sup>2-</sup> = Tridentate ONS Ligands) Species:  Syntheses, Structural Investigati... by Satyabrata Samanta (2305432)

    Published 2003
    “…The putative product is a mixed-oxidation (μ-oxo)divanadium(IV/V) species as revealed from EPR, electronic spectroscopy, dynamic <sup>1</sup>H NMR, and redox studies.…”
  14. 15074
  15. 15075

    Average tumor values of DCE-MRI derived parameters at different time points before and after PDT, for treated and non-treated animals. by Tom J. L. Schreurs (3335379)

    Published 2016
    “…Directly after PDT, the average tumor K<sup>trans</sup> decreased and v<sub>e</sub> increased significantly compared to baseline based on repeated measures (both: <i>p</i> < 0.0001), and also compared to untreated animals at the same time point (<i>p</i> < 0.0001 and <i>p</i> = 0.038, respectively).…”
  16. 15076
  17. 15077
  18. 15078
  19. 15079

    HIS-24 associates with promoters of <i>mab-5</i> and <i>egl-5</i> genes. by Maja Studencka (137195)

    Published 2012
    “…<p>(A) <i>mab-5</i> and <i>egl-5</i> genes are tightly clustered on chromosome III. …”
  20. 15080

    Baseline characteristics of participants<sup>a</sup>. by Yunmin Han (17729539)

    Published 2024
    “…The weighted prevalence of obesity in all ages significantly increased from 30.8% (29.1%-32.5%) in 2014 to 34.5% (32.9%-36.2%) in 2017 and 37.3% (35.5%-39.1%) in 2021 (<i>p</i> for trend < 0.004). …”